The relationship between non-coding RNA in exosomes and outcomes of thyrotropin receptor antibody (TRAb) of Graves'disease

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ITMCTR

Registry ID

ITMCTR1900002606

Enrollment

Unknown

Registered

2019-09-19

Start date

2019-09-19

Completion date

Unknown

Last updated

2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Graves' disease

Interventions

TRAb positive group of newly diagnosed and untreated GD patients:N/A

Healthy control group:N/A

GD with TRAb negative group after treatment:N/A

GD with TRAb persistent positive group after treatment:N/A

Eligibility

Sex/Gender

All

Age

18 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Understand the whole process of the trial, voluntarily participate in and sign the informed consent form; 2. Diagnosis with Graves disease; 3. Aged 18-50 yearsmale or female.

Exclusion criteria

Exclusion criteria: 1. GD patients treated with methods other than anti-thyroid durgs; 2. Taking other immunosuppressants other than ATD; 3. Alcohol abuse, drug addict; 4. Mentally ill and receiving treatment.

Design outcomes

Primary

Measure	Time frame
non-coding RNA;	—

Countries

China

Contacts

Public ContactBo Feng

Department of Endocrinology, Shanghai East Hospital, Tongji University School of Medicine

fengbodfyy@tongji.edu.cn+86 13301921056

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026